Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO

Currently, there are several novel spectacle designs available across the world. Unfortunately, none of them are available in the US currently.

Although the use of atropine is not necessarily novel in the myopia management world, the fact that practitioners may soon have an FDA approved formulation of atropine is new and exciting.

New research suggests sleep is an additional risk factor affecting myopia onset and progression.

In a sham device-controlled, randomized, double-blind clinical trial in China, researchers utilized a device that emits 650 nm red light directly to the retina.

Several eye conditions may benefit from membrane application.

Although the 20-20-20 rule is still a solid recommendation, recent studies have provided practitioners with more specific recommendations to help potentially prevent the onset and slow the progression of myopia.

Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO, shares key takeaways from her SECO 2023 panel discussion, "Myopia management."

Increasing scleral lens use can benefit a larger patient base.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on advanced fitting and troubleshooting tips for scleral lenses during the South Carolina Optometric Physicians Association’s annual meeting.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on amniotic membrane treatment for anterior segment disease during the South Carolina Optometric Physicians Association’s annual meeting.